{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-052879","form_type":"8-K","ticker":"ARDT","cik":"0001756655","company_name":"Ardent Health, Inc.","filed_at":"2025-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.346275+00:00","generated_at":"2026-05-16T18:51:14.102537+00:00","sec_items":["7.01","2.03","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Ardent Health authorizes $50M share repurchase program; $609M cash on hand","bullets":["Board authorized up to $50M in common stock repurchases; no expiration date.","CEO Marty Bonick cites conviction in business fundamentals and strong balance sheet.","Q3 2025 liquidity: $609M cash, lease-adjusted net leverage of 2.5x.","Program funded from existing cash; does not affect ability to pursue M&A or growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-052879","json":"https://secwatch.observer/filing/0001628280-25-052879.json","markdown":"https://secwatch.observer/filing/0001628280-25-052879.md","text":"https://secwatch.observer/filing/0001628280-25-052879.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1756655/000162828025052879/0001628280-25-052879-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1756655/000162828025052879/ardt-20251117.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:51:14.102537+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}